Lymphotoxin-α gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study

PLoS Genetics

Volumn 2, Issue 7, 2006, Pages 0990-0996

  Clarke, Robert ^a   Xu, Peng ^b   Bennett, Derrick ^a   Lewington, Sarah ^a   Zondervan, Krina ^c   Parish, Sarah ^a   Palmer, Alison ^a   Clark, Sarah ^a   Cardon, Lon ^c   Peto, Richard ^a   Lathrop, Mark ^b   Collins, Rory ^a  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^b CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FIBRINOGEN; LYMPHOTOXIN; CYTOKINE;

ADULT; ALLELE; ARTICLE; BASE MISPAIRING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; METABOLISM; MIDDLE AGED; RISK;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 33746597102     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0020107     Document Type: Article

References (29)

1. Cope AP (1998) Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol 10: 669-676.
2. LeBoeuf RC, Schreyer SA (1998) The role of tumour necrosis factor-α receptors in atherosclerosis. Trends Cardiovasc Med 8: 131-138.
3. Barath P, Fishbein MC, Berenson J, Helfant RH, Forrester JS (1990) Detection and localization of human tumour necrosis factor in human atheroma. Am J Cardiol 65: 297-302.
4. Schreyer SA, Vick CM, LeBoeuf RC (2002) Loss of lymphotoxin-α but not tumour necrosis factor-α reduces atherosclerosis in mice. J Biol Chem 277: 12364-12368.
5. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, et al. (2002) Functional SNP's in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32: 650-654.
6. Iwanaga Y, Ono K, Takagi S, Terashima M, Tsutsumi Y, et al. (2004) Association analysis between polymorphisms of the lymphotoxin-alpha gene and myocardial infarction in a Japanese population. Atherosclerosis 172: 197-198.
7. PROCARDIS Consortium (2004) A trio family study showing association of the lymphotoxin-α N26 (804A) allele with coronary artery disease. Eur J Hum Genet 12: 770-774.
8. Yamada A, Ichicara S, Murase Y, Kato T, Izawa H, et al. (2004) Lack of association of polymorphisms of the lymphotoxin-α gene with myocardial infarction in Japanese. J Mol Med 282: 477-483.
9. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, et al. (2004) Genotypes and haplotypes predisposing to myocardial infarction: A multilocus case-control study. Eur Heart J 25: 459-467.
10. Brown B, Lawrence R, Cheng S, Barrett J, Balmforth A, et al. (2006) Lack of association between premature myocardial infarction and the lymphotoxin-α C804A polymorphism in a UK discordant sibling population. Eur J Hum Genet In press.
11. Zondervan K, Cardon LR (2004) The complex interplay among factors that influence allelic association. Nat Rev Genet 5: 89-100.
12. Marchini J, Cardon LR, Phillips MS, Donnelly P (2004) The effects of human population structure on large genetic association studies. Nat Genet 36: 512-517.
13. ISIS-3 (Third International Study of Infarct Survival Collaborative Group) (1992) ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 339: 753-770.
14. Wittke-Thompson JK, Pluzhnikov A, Cox NJ (2005) Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76: 967-986.
15. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437: 1299-1320.
16. Sterne JA, Egger M, Smith GD (2001) Investigating and dealing with publication and other biases in meta-analysis. BMJ 323: 101-105.
17. Keavney B, McKenzie C, Parish S, Palmer A, Clark S, et al. (2000) Large-scale test of hypothesised associations between the angiotensin- converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 355: 434-442.
18. Keavney B, Palmer A, Parish S, Clark S, Youngman L, et al. for the International Studies of Infarct Survival (ISIS) Collaborators (2004) Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: Discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol 33: 1002-1013.
19. MRC/BHF Heart Protection Study Collaborative Group (1999) MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 20: 725-741.
20. Clark S, Youngman LD, Palmer A, Parish S, Peto R, et al. (2003) Stability of plasma analytes after delayed separation of whole blood: Implications for epidemiological studies. Int J Epidemiol 32: 125-130.
21. Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120: 849-852.
22. Hill WG, Robertson A (1968) Linkage disequilibrium in finite populations. Theor Appl Genet 38: 226-231.
23. Schaid DJ, Rowland CM, Tines DE, Jacobsen RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genetics 70: 425-434.
24. Easton DF, Peto J, Babiker AG (1991) Floating absolute risk: An alternative to relative risk in survival in case-control analysis avoiding an arbitrary reference group. Stat Med 10: 1025-1035.
25. Plummer M (2004) Improved estimates of floating absolute risk. Stat Med 23: 93-104.
26. Slager SL, Schaid DJ (2001) Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend. Hum Hered 52: 149-153.
27. Friedlin B, Zheng G, Zhaohai L, Gastwirth JL (2002) Trend tests for case-control studies of genetic markers: Power, sample size and robustness. Hum Hered 53: 146-152.
28. Thompson SG (1994) Why sources of heterogeneity in meta-analysis should be investigated. BMJ 309: 1351-1355.
29. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 27: 335-371.